SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-196716
Filing Date
2021-06-23
Accepted
2021-06-23 07:02:02
Documents
14
Period of Report
2021-06-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d182380d8k.htm   iXBRL 8-K 25338
2 EX-99.1 d182380dex991.htm EX-99.1 12700
6 GRAPHIC g182380g02k14.jpg GRAPHIC 6714
  Complete submission text file 0001193125-21-196716.txt   174207

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krtx-20210623.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20210623_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20210623_pre.xml EX-101.PRE 11399
7 EXTRACTED XBRL INSTANCE DOCUMENT d182380d8k_htm.xml XML 3343
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 211037192
SIC: 2834 Pharmaceutical Preparations